HIZENTRA Trademark

Trademark Overview

On Tuesday, February 17, 2009, a trademark application was filed for HIZENTRA with the United States Patent and Trademark Office. The USPTO has given the HIZENTRA trademark a serial number of 77672094. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, August 10, 2020. This trademark is owned by CSL Behring AG. The HIZENTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy
hizentra

General Information

Serial Number77672094
Word MarkHIZENTRA
Filing DateTuesday, February 17, 2009
Status800 - REGISTERED AND RENEWED
Status DateMonday, August 10, 2020
Registration Number3822764
Registration DateTuesday, July 20, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy
Translation of Words in MarkThe wording "HIZENTRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 20, 2009
Primary Code005
First Use Anywhere DateThursday, April 15, 2010
First Use In Commerce DateThursday, April 15, 2010

Trademark Owner History

Party NameCSL Behring AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBern 22 CH-3000
CH
Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-3000, Bern 22
CH
Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-3000, Bern 22
CH

Trademark Events

Event DateEvent Description
Monday, August 10, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, August 10, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, August 10, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 10, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 15, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, July 20, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 17, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 17, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 16, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 16, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 8, 2016TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 20, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 21, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, June 16, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 15, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, June 14, 2010ASSIGNED TO LIE
Friday, May 28, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 27, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 11, 2010USE AMENDMENT FILED
Thursday, May 27, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 11, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, December 15, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2009PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2009NOTICE OF PUBLICATION
Monday, August 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 14, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 14, 2009EXAMINER'S AMENDMENT ENTERED
Friday, August 14, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 14, 2009EXAMINERS AMENDMENT E-MAILED
Friday, August 14, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, August 3, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 3, 2009NON-FINAL ACTION E-MAILED
Monday, August 3, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 29, 2009AMENDMENT FROM APPLICANT ENTERED
Wednesday, July 29, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 27, 2009PAPER RECEIVED
Thursday, May 7, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 7, 2009NON-FINAL ACTION E-MAILED
Thursday, May 7, 2009NON-FINAL ACTION WRITTEN
Thursday, May 7, 2009ASSIGNED TO EXAMINER
Thursday, March 26, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 26, 2009ASSIGNED TO LIE
Thursday, March 26, 2009PAPER RECEIVED
Friday, February 20, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 20, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

hizentra deficiency immuno disorders treatment replacement therapy immune intravenous preparations pharmaceutical